血友病A(Hemophilia A)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hemophilia A 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hemophilia A 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Hemophilia A Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Hemophilia A 34
Dec 17, 2014: LFB Announces Achievement of Patient Enrollment Target for PerSept 1 Program for the Evaluation of Recombinant Factor Seven Efficacy by Prospective Clinical Trials 34
Dec 09, 2014: Roche presents data for hemophilia A therapy ACE910 34
Dec 07, 2014: NovoEight, phase 3 data show reduction in annualised bleeding rate over time in people with haemophilia A 35
Dec 05, 2014: Roche to present clinical data on ACE910 at ASH 35
Dec 01, 2014: Bayer to Present Latest Data on Its Kogenate FS At ASH 56th Annual Meeting 36
Dec 01, 2014: Bayer to Present Latest Data on Its Damoctocog alfa pegol (BAY 94-9027) 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Novo A/S 38
Clinical Trial Overview of Novo A/S 38
Baxter International Inc. 42
Clinical Trial Overview of Baxter International Inc. 42
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
CSL Limited 49
Clinical Trial Overview of CSL Limited 49
Octapharma AG 51
Clinical Trial Overview of Octapharma AG 51
Biogen Idec Inc. 53
Clinical Trial Overview of Biogen Idec Inc. 53
Grifols, S.A. 54
Clinical Trial Overview of Grifols, S.A. 54
F. Hoffmann-La Roche Ltd. 55
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 55
Bio Products Laboratory Ltd. 56
Clinical Trial Overview of Bio Products Laboratory Ltd. 56
Clinical Trial Overview of Top Institutes / Government 57
National Heart, Lung, and Blood Institute 57
Clinical Trial Overview of National Heart, Lung, and Blood Institute 57
University of Pittsburgh 58
Clinical Trial Overview of University of Pittsburgh 58
Weill Cornell Medical College 59
Clinical Trial Overview of Weill Cornell Medical College 59
The Hospital for Sick Children 60
Clinical Trial Overview of The Hospital for Sick Children 60
NewYork- Presbyterian Hospital 61
Clinical Trial Overview of NewYork- Presbyterian Hospital 61
The Sheba Medical Center 62
Clinical Trial Overview of The Sheba Medical Center 62
Georgetown University 63
Clinical Trial Overview of Georgetown University 63
City of Hope 64
Clinical Trial Overview of City of Hope 64
Skane University Hospital 65
Clinical Trial Overview of Skane University Hospital 65
Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico 66
Clinical Trial Overview of Fondazione IRCCS Ca’ Granda – Ospedale Maggiore Policlinico 66
Five Key Clinical Profiles 67
Appendix 110
Abbreviations 110
Definitions 110
Research Methodology 111
Secondary Research 111
About GlobalData 112
Contact Us 112
Disclaimer 112
Source 112